Fig. 3: K560/576/591 are the acetylation sites of Cry2.
From: Cryptochrome 2 acetylation attenuates its antiproliferative effect in breast cancer
A Schematic diagram of the process of identifying Cry2 acetylation sites. B MS analysis of the Cry2-derived peptides containing acetylated K591. C Mass spectrometry analysis identification of the Cry2-derived peptides containing potential acetylated sites. D The potential acetylation sites of Cry2 are conserved in multiple species. E Monomutation of the potential acetylated lysine reduced the acetylation level of Cry2. F The acetylation of Cry2–3KR was abolished.
